HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Cardiovascular Complications and Diabetes

The interplay between cardiovascular complications and diabetes presents a significant challenge in patient management. Chronic hyperglycemia, insulin resistance, and dyslipidemia contribute to atherosclerosis, increasing the risk of heart attacks and strokes. Emerging evidence supports the cardioprotective effects of GLP-1 receptor agonists and SGLT2 inhibitors, offering benefits beyond glucose control. Continuous monitoring of blood pressure, lipid profiles, and inflammatory markers is essential for early intervention. Lifestyle modifications, such as dietary adjustments and structured exercise programs, complement pharmacological strategies in reducing cardiovascular risk. Advances in precision cardiology and personalized treatments are paving the way for improved long-term outcomes in diabetic patients.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp